Mirae Asset Global Investments Co., Ltd. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 95 filers reported holding RELMADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$777,027
-6.8%
259,009
-23.6%
0.00%0.0%
Q2 2023$833,805
+27.7%
338,945
+17.3%
0.00%0.0%
Q1 2023$653,018
-33.0%
288,946
+3.4%
0.00%
-33.3%
Q4 2022$975,158
-63.4%
279,415
+287.9%
0.00%
-57.1%
Q3 2022$2,667,000
+413.9%
72,033
+65.8%
0.01%
+600.0%
Q2 2022$519,00043,4440.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders